Programme Result - UK NEQAS

ACCREDITATION STATUS:

UKAS Accredited

CLINICAL APPLICATION:

Chronic Lymphocytic Leukaemia (CLL) Myelodysplastic syndrome (MDS)

PURPOSE OF PROGRAMME:

Analysis and interpretation of recurrent and non-recurrent copy number changes in chronic lymphocytic leukaemia and myeloid disorders: DNA for array or NGS studies.

MATERIAL PROVIDED: DNA in TE buffer

DISTRIBUTIONS PER YEAR: 1

SAMPLES PER DISTRIBUTION: 2

FREQUENCY OF DISTRIBUTION: 1

PROGRAMME OF ANALYSIS:

Whole genome copy number changes and structural rearrangements.

DATA ANALYSIS:

Clinical Report

Details of the performance criteria for this programme can be obtained from UK NEQAS Genomics (GenQA) directly.

Email: info@genqa.org
Telephone: +44 (0) 131 2426898

Genomics (GenQA)

From 1st January 2018, Cytogenomics External Quality Assessment Service (CEQAS) and UK National External Quality Assessment Service (UK NEQAS) for Molecular Genetics merged to become Genomics Quality Assessment (GenQA). Please click here for an overview of GenQA

Contact Details

Genomics (GenQA)

GenQA (Edinburgh)
Department of Laboratory Medicine
The Royal Infirmary of Edinburgh
Little France Crescent
Edinburgh
EH16 4SA

Data Entry

Acquired array (CLL and MDS)

Summary

ACCREDITATION STATUS:

CLINICAL APPLICATION:

PURPOSE OF PROGRAMME:

Analysis

PROGRAMME OF ANALYSIS:

DATA ANALYSIS:

Performance

About the Centre

Genomics (GenQA)

Contact Details

Genomics (GenQA)